Pharma has been witnessing a surge in M&A in past three years. The industry is averting from a sustainable “research to grow” strategy to “buy to grow” strategy. These M&A are backed by strategic business reasons.

Let’s discover the reason behind some of the major deals-

Speak to an expert

Book a call to speak to one of our experts.

Speak to expert